Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series

Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard for genetic analyses, but in some cases, such as w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bursac, Daliborka, Zarić, Bojan, Kovačević, Tomi, Stojšić, Vladimir, Vagionas, Anastasios, Boukovinas, Ioannis, Tsakiridis, Kosmas, Kosmidis, Christoforos, Sapalidis, Konstantinos, Romanidis, Konstantinos, Courcoutsakis, Nikolaos, Matthaios, Dimitris, Zarogoulidis, Paul, Sardeli, Chrysanthi, Sekerus, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215970/
https://www.ncbi.nlm.nih.gov/pubmed/34177521
http://dx.doi.org/10.1159/000515506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215970/
https://www.ncbi.nlm.nih.gov/pubmed/34177521
http://dx.doi.org/10.1159/000515506

Ejemplares similares